Staff Members - Benha University
Study of serum YKL-40 in children with bronchial asthma
• 2018
Publication Information
Authors
Iman A. Mohammed a, Safia M. Diab b, Doaa R. Soliman a, Wael A. Shalaby
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Serum YKL-40 (chitinase-3-like-1) has recently been found to be either the
cause or a biomarker for asthma. This study quantifies serum levels of YKL-40 in asthmatic children
and evaluates the relationship between YKL-40 and asthma severity.
Methods: We quantified serum YKL-40 levels in two groups of asthmatic children (aged between 2
and 12 years). Group 1 (n: 30) in between the attack (stable group) and group 2 (n: 30) during the
exacerbation (acute attack group). Serum YKL-40 was measured by enzyme-linked immunosorbent
assay (ELIZA) Kits (WKEA MED SUPPLIES CORP). We measured blood eosinophils and peak
expiratory flow rate for children >5 years.
Results: Serum levels of YKL-40 were significantly elevated in the acute asthma group and in the
stable asthma group compared to the control group (673.92 ± 24.23 ng/ml, 552.73± 57.34 ng/ml,
136.17± 53.14) respectively, P < 0.001. YKL-40 levels were correlated positively with blood eosinophils
in the stable group (q = 0.67, P
cause or a biomarker for asthma. This study quantifies serum levels of YKL-40 in asthmatic children
and evaluates the relationship between YKL-40 and asthma severity.
Methods: We quantified serum YKL-40 levels in two groups of asthmatic children (aged between 2
and 12 years). Group 1 (n: 30) in between the attack (stable group) and group 2 (n: 30) during the
exacerbation (acute attack group). Serum YKL-40 was measured by enzyme-linked immunosorbent
assay (ELIZA) Kits (WKEA MED SUPPLIES CORP). We measured blood eosinophils and peak
expiratory flow rate for children >5 years.
Results: Serum levels of YKL-40 were significantly elevated in the acute asthma group and in the
stable asthma group compared to the control group (673.92 ± 24.23 ng/ml, 552.73± 57.34 ng/ml,
136.17± 53.14) respectively, P < 0.001. YKL-40 levels were correlated positively with blood eosinophils
in the stable group (q = 0.67, P